REMAP Amgen Eisai 102620-300news.jpg

GCAR, Amgen, & Eisai Announce First Patient Enrolled in International COVID-19 Trial
Wednesday, October 28, 2020 9:36 PM

AMGEN and Eisai to Participate in the Immune Modulation Domain of REMAP-COVID, an Adaptive Clinical Trial to Test Interventions for Patients Hospitalized with COVID-19

AMGEN’s Apremilast and Eisai’s Eritoran to be Evaluated Across Multiple International Trial Sites Within the Remap Network

On October 26, 2020, the Global Coalition for Adaptive Research… Read more…

Ericka Fink, MD, MS Awarded an INCLINE Grant from the Neurocritical Care Society

Pediatric critical care investigator Ericka Fink, MD, MS has been awarded an INCLINE grant from the Neurocritical Care Society to…

Pitt Septic Shock Researchers Among World's Top 0.1%

Five faculty members in the Department of Critical Care Medicine have propelled the University of Pittsburgh to number three in…

Corticosteroids Improve Survival in Critically Ill COVID-19 Patients

UPMC Announces Results of International Trial

In a tremendous demonstration of global collaboration, an international team led by clinician-scientists at

Nahmah Kim-Campbell, MD, MS Awarded K23 Grant to Study Renal Injury After Cardiopulmonary Bypass

Assistant Professor Nahmah Kim-Campbell, MD, MS was awarded a K23 grant entitled “Mechanisms of Cell-Free Plasma Hemoglobin-Mediated Renal Injury After…

Full news archive >


Full events calendar >

"We experienced the frustrations of trying to provide respirator care for unconscious patient care in various locations of the hospital without the help of trained inhalation therapists and specialty trained nurses. In 1958 therefore, we initiated and established an Intensive Care Unit adjacent to the post-anesthesia recovery room."

- Peter Safar, MD, cardiopulmonary resuscitation pioneer